Answer
Carfilzomib (Kyprolis) is indicated for adults with multiple myeloma who have received at least one prior therapy, in combination with daratumumab and dexamethasone, lenalidomide and dexamethasone, or dexamethasone alone.
Sources for this answer
- KyprolisAmgen Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 21Document updated
Sources checked